A multivariate cognitive approach to predict social functioning in recent onset psychosis in response to computerized cognitive training.

Machine learning Recent onset psychosis Social cognitive training Social functioning Treatment response

Journal

Progress in neuro-psychopharmacology & biological psychiatry
ISSN: 1878-4216
Titre abrégé: Prog Neuropsychopharmacol Biol Psychiatry
Pays: England
ID NLM: 8211617

Informations de publication

Date de publication:
10 Jan 2024
Historique:
received: 09 05 2023
revised: 01 08 2023
accepted: 13 09 2023
pubmed: 18 9 2023
medline: 18 9 2023
entrez: 17 9 2023
Statut: ppublish

Résumé

Clinical and neuroimaging data has been increasingly used in recent years to disentangle heterogeneity of treatment response to cognitive training (CT) and predict which individuals may achieve the highest benefits. CT has small to medium effects on improving cognitive and social functioning in recent onset psychosis (ROP) patients, who show the most profound cognitive and social functioning deficits among psychiatric patients. We employed multivariate pattern analysis (MVPA) to investigate the potential of cognitive data to predict social functioning improvement in response to 10 h of CT in patients with ROP. A support vector machine (SVM) classifier was trained on the naturalistic data of the Personalized Prognostic Tools for Early Psychosis Management (PRONIA) study sample to predict functioning in an independent sample of 70 ROP patients using baseline cognitive data. PRONIA is a part of a FP7 EU grant program that involved 7 sites across 5 European countries, designed and conducted with the main aim of identifying (bio)markers associated with an enhanced risk of developing psychosis in order to improve early detection and prognosis. Social functioning was predicted with a balanced accuracy (BAC) of 66.4% (Sensitivity 78.8%; Specificity 54.1%; PPV 60.5%; NPV 74.1%; AUC 0.64; P = 0.01). The most frequently selected cognitive features (mean feature weights > ± 0.2) included the (1) correct number of symbol matchings within the Digit Symbol Substitution Test, (2) the number of distracting stimuli leading to an error within 300 and 200 trials in the Continuous Performance Test and (3) the dynamics of verbal fluency between 15 and 30 s within the Verbal Fluency Test, phonetic part. Next, the SVM classifier generated on the PRONIA sample was applied to the intervention sample, that obtained 54 ROP patients who were randomly assigned to a social cognitive training (SCT) or treatment as usual (TAU) group and dichotomized into good (GF-S ≥ 7) and poor (GF-S < 7) functioning patients based on their level of Global Functioning-Social (GF-S) score at follow-up (FU). By applying the initial PRONIA classifier, using out-of-sample cross-validation (OOCV) to the sample of ROP patients who have undergone the CT intervention, a BAC of 59.3% (Sensitivity 70.4%; Specificity 48.1%; PPV 57.6%; NPV 61.9%; AUC 0.63) was achieved at T0 and a BAC of 64.8% (Sensitivity 66.7%; Specificity 63.0%; PPV 64.3%; NPV 65.4%; AUC 0.66) at FU. After SCT intervention, a significant improvement in predicted social functioning values was observed in the SCT compared to TAU group (P ≤0.05; ES[Cohens' d] = 0.18). Due to a small sample size and modest variance of social functioning of the intervention sample it was not feasible to predict individual response to SCT in the current study. Our findings suggest that the use of baseline cognitive data could provide a robust individual estimate of future social functioning, while prediction of individual response to SCT using cognitive data that can be generated in the routine patient care remains to be addressed in large-scale cognitive training trials.

Identifiants

pubmed: 37717645
pii: S0278-5846(23)00150-1
doi: 10.1016/j.pnpbp.2023.110864
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

110864

Informations de copyright

Copyright © 2023 Elsevier Inc. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of Competing Interest This study was supported by EU-FP7 project PRONIA (Personalized Prognostic Tools for Early Psychosis Management) under the Grant Agreement No° 602152 (PI: NK), NARSAD Young Investigator Award of the Brain & Behavior Research Foundation No° 28474 (PI: LK-I) and LMU excellent (LKI). NK, JK and RKRA are currently honorary speakers for Otsuka/Lundbeck. RU received grants from Medical Research Council, grants from the National Institute for Health Research, and personal fees from Sunovion. C Pantelis was supported by a National Health and Medical Research Council (NHMRC) Senior Principal Research Fellowship (1105825), an aNHMRC L3 Investigator Grant (1196508), and NHMRC-EU grant (1075379). SSH is supported by NIH National Institute of Mental Health, grant T32MH122394. The remaining authors including members of the PRONIA consortium have nothing to disclose.

Auteurs

Nina Walter (N)

Department of Psychiatry and Psychotherapy, Faculty of Medicine and University Hospital, University of Cologne, Kerpenerstr.62, 50931, Cologne, Germany.

Julian Wenzel (J)

Department of Psychiatry and Psychotherapy, Faculty of Medicine and University Hospital, University of Cologne, Kerpenerstr.62, 50931, Cologne, Germany.

Shalaila S Haas (SS)

Department of Psychiatry, Icahn School of Medicine at Mount Sinai, NY, New York, United States of America.

Letizia Squarcina (L)

Scientific Institute, IRCCS E. Medea, Pasian di Prato, Udine, Italy.

Carolina Bonivento (C)

Scientific Institute, IRCCS E. Medea, Pasian di Prato, Udine, Italy.

Anne Ruef (A)

Department of Psychiatry and Psychotherapy, Ludwig-Maximilian University, Munich, Germany.

Dominic Dwyer (D)

Department of Psychiatry and Psychotherapy, Ludwig-Maximilian University, Munich, Germany; Orygen Youth Health, Melbourne, Australia; Centre for Youth Mental Health, University of Melbourne, Melbourne, Australia.

Theresa Lichtenstein (T)

Department of Psychiatry and Psychotherapy, Faculty of Medicine and University Hospital, University of Cologne, Kerpenerstr.62, 50931, Cologne, Germany.

Öznur Bastrük (Ö)

Department of Psychiatry and Psychotherapy, Faculty of Medicine and University Hospital, University of Cologne, Kerpenerstr.62, 50931, Cologne, Germany.

Alexandra Stainton (A)

Orygen Youth Health, Melbourne, Australia; Centre for Youth Mental Health, University of Melbourne, Melbourne, Australia.

Linda A Antonucci (LA)

Department of Translational Biomedicine and Neuroscience, University of Bari Aldo Moro, Bari, Italy.

Paolo Brambilla (P)

Department of Neuosciences and Mental Health, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy; Department of Pathophysiology and Mental Health, University of Milan, Milan, Italy.

Stephen J Wood (SJ)

Orygen Youth Health, Melbourne, Australia; School of Psychology, University of Birmingham, United Kingdom; Centre for Youth Mental Health, University of Melbourne, Melbourne, Australia.

Rachel Upthegrove (R)

School of Psychology, University of Birmingham, United Kingdom; Institute of Mental Health, University of Birmingham, Birmingham, United Kingdom.

Stefan Borgwardt (S)

Translational Psychiatry Unit (TPU), Department of Psychiatry and Psychotherapy, University of Luebeck, Germany.

Rebekka Lencer (R)

Translational Psychiatry Unit (TPU), Department of Psychiatry and Psychotherapy, University of Luebeck, Germany.

Eva Meisenzahl (E)

Department of Psychiatry and Psychotherapy, Medical Faculty, Heinrich-Heine University, Düsseldorf, Germany.

Raimo K R Salokangas (RKR)

Department of Psychiatry, University of Turku, Turku, Finland.

Christos Pantelis (C)

Melbourne Neuropsychiatry Centre, Department of Psychiatry, University of Melbourne & NorthWestern Mental Health, Melbourne, Australia.

Alessandro Bertolino (A)

Department of Translational Biomedicine and Neuroscience, University of Bari Aldo Moro, Bari, Italy.

Nikolaos Koutsouleris (N)

Department of Psychiatry and Psychotherapy, Ludwig-Maximilian University, Munich, Germany; Max Planck Institute for Psychiatry, Munich, Germany; Institute of Psychiatry, Psychology & Neuroscience, Department of Psychosis Studies, King's College London, London, United Kingdom.

Joseph Kambeitz (J)

Department of Psychiatry and Psychotherapy, Faculty of Medicine and University Hospital, University of Cologne, Kerpenerstr.62, 50931, Cologne, Germany.

Lana Kambeitz-Ilankovic (L)

Department of Psychiatry and Psychotherapy, Faculty of Medicine and University Hospital, University of Cologne, Kerpenerstr.62, 50931, Cologne, Germany; Faculty of Psychology and Educational Sciences, Department of Psychology, Ludwig-Maximilian University, Munich, Germany. Electronic address: lana.kambeitz-ilankovic@uk-koeln.de.

Classifications MeSH